Targeted News Service

AlloSource Announces First Patient Implantation in United Kingdom Clinical Evaluation of ProChondrix CR Cryopreserved Osteochondral Allograft
November 01, 2023

CENTENNIAL, Colorado, Nov. 1 (TNSres) -- AlloSource issued the following news release on Oct. 31, 2023:

AlloSource, one of the United States leading innovators and manufacturers of cartilage for joint preservation, today announced the first patient implantation of ProChondrix(R) CR Cryopreserved Osteochondral Allograft in a United Kingdom (UK) independent evaluation. The procedure was conducted by Dr. Nick Smith, D.O., a knee specialist orthopedic surgeon with University Hospitals C . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form